Paul F. Kantor - Concepedia

Author

Paul F. Kantor

Also Known As

Mike Seed, P F Kantor, P Kantor, P. F. Kantor, P. Kantor, P.F. Kantor, PAUL F. KANTOR, PAUL KANTOR, Paul F Kantor, Paul F. KANTOR

225

Publications

9.2K

Citations

H-Index

103

Concepts

All Affiliations

Hospital for Sick Children University of Toronto University of Alberta Stollery Children's Hospital SickKids Foundation

About

Paul F. Kantor is an author at Hospital for Sick Children specializing in medicine, cardiology, and heart failure.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	47	5.3K
2	Health Sciences	9	9	1.2K
3	Public Health	9	9	1.6K
4	Education	2	2	78
5	Natural Sciences	1	1	39

Paul F. Kantor

Publications

7.4K

Citations

H-Index

Page 1

	Year	Citations
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary Steve R. Ommen, Seema Mital, Michael A. Burke, Journal of the American College of Cardiology CardiomyopathyStructural Heart DiseaseCardiovascular DiseaseHypertrophic CardiomyopathyCardiac Care	2020	983
The Antianginal Drug Trimetazidine Shifts Cardiac Energy Metabolism From Fatty Acid Oxidation to Glucose Oxidation by Inhibiting Mitochondrial Long-Chain 3-Ketoacyl Coenzyme A Thiolase Paul F. Kantor, Arnaud Lucien, Raymond Kozak, Circulation Research Heart FailureLipid PeroxidationMetabolic RemodelingCardiovascular ToxicityOxidative Stress	2000	802
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy Steve R. Ommen, Seema Mital, Michael A. Burke, Journal of the American College of Cardiology CardiomyopathyStructural Heart DiseaseCardiovascular DiseaseHypertrophic CardiomyopathyCardiac Care	2020	651
Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG) Ray E. Hershberger, Michael M. Givertz, Carolyn Y. Ho, Genetics in Medicine CardiomyopathyCardiovascular DiseaseGeneticsGenetic EvaluationAmerican College	2018	273
Presentation, Diagnosis, and Medical Management of Heart Failure in Children: Canadian Cardiovascular Society Guidelines Paul F. Kantor, Jane Lougheed, Adrian Dancea, Canadian Journal of Cardiology Family MedicineHeart FailureCardiovascular DiseasePediatric Heart DiseasePediatrics	2013	256
Reduction of ischemic K+ loss and arrhythmias in rat hearts. Effect of glibenclamide, a sulfonylurea. Paul F. Kantor, William A. Coetzee, Edward Carmeliet, Circulation Research Heart FailureCardiac AnaesthesiaCardiovascular PharmacologyPharmacotherapyExperimental Pharmacology	1990	223
Outcomes of Restrictive Cardiomyopathy in Childhood and the Influence of Phenotype Steven A. Webber, Steven E. Lipshultz, Lynn A. Sleeper, Circulation	2012	216
A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy Anastasia Miron, Myriam Lafrenière‐Roula, Chun‐Po Steve Fan, Circulation	2020	212
Cardiomyopathy Phenotypes and Outcomes for Children With Left Ventricular Myocardial Noncompaction: Results From the Pediatric Cardiomyopathy Registry John L. Jefferies, James D. Wilkinson, Lynn A. Sleeper, Journal of Cardiac Failure Cardiomyopathy PhenotypesCardiomyopathyHeart FailureCardiovascular DiseasePediatric Heart Disease	2015	173
Incidence of and Risk Factors for Sudden Cardiac Death in Children With Dilated Cardiomyopathy Elfriede Pahl, Lynn A. Sleeper, Charles E. Canter, Journal of the American College of Cardiology CardiomyopathyHeart FailureCardiovascular DiseasePediatric Heart DiseasePediatrics	2012	167

Page 1